ETFs with PRGO as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.29%||SPDR S&P Pharmaceuticals ETF (XPH)||+14.91 (27.05%)|
|3.57%||iShares NASDAQ Biotechnology Index Fund (IBB)||+46.33 (34.33%)|
|3.22%||iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE)||+18.79 (22.37%)|
|2.47%||PowerShares Dynamic Heathcare (PTH)||+6.21 (19.11%)|
|1.81%||First Trust NASDAQ-100 Ex-Technology Sector Index Fund (QQXT)||+2.76 (11.29%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Perrigo Company, established in 1887, is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world’s largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company’s primary markets and locations of manufacturing and logistics operations are the United States (U.S.), Israel, Mexico, the United Kingdom (U.K.) and Australia. See Note 17 of the Notes to Consolidated Financial Statements for further information. Perrigo Company operates through several wholly owned subsidiaries. In the U.S., its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., Perrigo Holland, Inc. (formerly J.B. Laboratories, Inc. ... More ...